MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acsptsci.1c00264

Медицинская библиотека · ACS pharmacology & translational science · 2022

Development of Ultrapure and Potent Tannic Acids as a Pan-coronal Antiviral Therapeutic.

Shih Po-Chang, Mao Yi-Wen, Hu Jhe-Wei, Hsieh Han-Yi, Shih Tsai-Miao, Lu Lu-Ping, Chang Wei-Hua, Huang Chan-Hui, Lin Chia-Hung, Lin Chih-Hung, Tan Peng, Yang Ya-Ching, Chien Ming-Hong, Su Chen-Che, Yeh Cheng-Hsin, Chuang Pei-Yun, Hsieh Tien-Lan, Wang Ching-Cheng, Hsieh Po-Shiuan, Chou Teh-Ying, Tsai Guochuan Emil

СтатьяПеревод в очереди

Аннотация

The rampageous transmission of SARS-CoV-2 has been devastatingly impacting human life and public health since late 2019. The waves of pandemic events caused by distinct coronaviruses at present and over the past decades have prompted the need to develop broad-spectrum antiviral drugs against them. In this study, our Pentarlandir ultrapure and potent tannic acids (UPPTA) showed activities against two coronaviral strains, SARS-CoV-2 and HCoV-OC43, the earliest-known coronaviruses. The mode of inhibition of Pentarlandir UPPTA is likely to act on 3-chymotrypsin-like protease (3CLpro) to prevent viral replication, as supported by results of biochemical analysis, a 3CLpro assay, and a "gain-of-function" 3CLpro overexpressed cell-based method. Even in the 3CLpro overexpressed environment, Pentarlandir UPPTA remained its antiviral characteristic. Utilizing cell-based virucidal and cytotoxicity assays, the 50% effective concentrations (EC50) and 50% cytotoxicity concentration (CC50) of Pentarlandir UPPTA were determined to be ∼0.5 and 52.5 μM against SARS-CoV-2, while they were 1.3 and 205.9 μM against HCoV-OC43, respectively. In the pharmacokinetic studies, Pentarlandir UPPTA was distributable at a high level to the lung tissue with no accumulation in the body, although the distribution was affected by the food effect. With further investigation in toxicology, Pentarlandir UPPTA demonstrated an overall safe toxicology profile. Taking these findings together, Pentarlandir UPPTA is considered to be a safe and efficacious pancoronal antiviral drug candidate that has been advanced to clinical development.

Для цитирования: Shih Po-Chang, Mao Yi-Wen, Hu Jhe-Wei, Hsieh Han-Yi, Shih Tsai-Miao, Lu Lu-Ping, Chang Wei-Hua, Huang Chan-Hui, Lin Chia-Hung, Lin Chih-Hung, Tan Peng, Yang Ya-Ching, Chien Ming-Hong, Su Chen-Che, Yeh Cheng-Hsin, Chuang Pei-Yun, Hsieh Tien-Lan, Wang Ching-Cheng, Hsieh Po-Shiuan, Chou Teh-Ying, Tsai Guochuan Emil. Development of Ultrapure and Potent Tannic Acids as a Pan-coronal Antiviral Therapeutic.. ACS pharmacology & translational science. 2022. DOI: 10.1021/acsptsci.1c00264.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.